Logo image of MRNA

MODERNA INC (MRNA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:MRNA - US60770K1079 - Common Stock

31.605 USD
+0.75 (+2.41%)
Last: 1/5/2026, 1:51:57 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MRNA revenue by date.MRNA revenue by date.
19.263B
4.29%
6.848B
-64.45%
3.236B
-52.75%
1.938B
-40.11%
1.98B
2.17%
2.3B
16.16%
3.288B
42.96%
5.759B
75.15%
8.233B
42.96%
6.138B
-25.45%
6.98B
13.72%
EBITDA
YoY % growth
MRNA ebitda by date.MRNA ebitda by date.
9.768B
-27.79%
-1.418B
-114.52%
-3.261B
-129.97%
-3.191B
2.13%
-2.684B
15.91%
-1.769B
34.07%
28.56M
101.61%
1.113B
3,797.06%
1.828B
64.24%
2.337B
27.84%
2.946B
26.06%
EBIT
YoY % growth
MRNA ebit by date.MRNA ebit by date.
9.42B
-29.15%
-2.039B
-121.65%
-3.45B
-69.20%
-3.481B
-0.89%
-2.975B
14.52%
-2.078B
30.16%
-1.359B
34.60%
63.941M
104.70%
1.465B
2,191.17%
1.076B
-26.55%
1.662B
54.46%
Operating Margin
MRNA operating margin by date.MRNA operating margin by date.
48.90%-29.78%-106.61%-179.60%-150.27%-90.35%-41.33%1.11%17.79%17.53%23.81%
EPS
YoY % growth
MRNA eps by date.MRNA eps by date.
19.96
-29.45%
-12.41
-162.17%
-9.28
25.22%
-8.22
11.47%
-7.11
13.51%
-5.01
29.56%
-2.97
40.76%
1.38
146.64%
4.63
234.81%
3.38
-27.02%
4.58
35.41%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-2.77
4.65%
-2.23
11.56%
-2.23
-4.63%
-1.03
-102.50%
-1.28
53.94%
Revenue
Q2Q % growth
659.58M
-31.72%
255.67M
136.73%
123.93M
-12.73%
909.64M
-10.47%
706.85M
7.17%
EBITDA
Q2Q % growth
-1.128B
-30.56%
-711.637M
26.56%
-667.913M
13.59%
-154.968M
-244.37%
N/A
EBIT
Q2Q % growth
-1.135B
-7.79%
-919.853M
8.74%
-927.606M
-6.74%
-437.232M
-126.54%
-629.215M
44.56%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.51
-1,800.00%
-2.151.6476.27%
Q2 2025
Q2Q % growth
-2.13
36.04%
-3.030.9029.60%
Q1 2025
Q2Q % growth
-2.52
17.92%
-3.200.6821.22%
Q4 2024
Q2Q % growth
-2.91
-629.09%
-2.74-0.17-6.26%
Q3 2024
Q2Q % growth
0.03
100.31%
-1.951.98101.54%
Q2 2024
Q2Q % growth
-3.33
8.01%
-3.450.123.51%
Q1 2024
Q2Q % growth
-3.07
-1,715.79%
-3.660.5916.04%
Q4 2023
Q2Q % growth
0.55
-84.76%
-0.991.54155.49%
Q3 2023
Q2Q % growth
-9.53
-476.68%
-1.97-7.56-384.77%
Q2 2023
Q2Q % growth
-3.62
-169.08%
-4.120.5012.15%
Q1 2023
Q2Q % growth
0.19
-97.79%
-1.812.00110.52%
Q4 2022
Q2Q % growth
3.61
-68.02%
4.77-1.16-24.31%
Q3 2022
Q2Q % growth
2.53
-67.14%
3.36-0.83-24.66%
Q2 2022
Q2Q % growth
5.24
-18.89%
4.640.6012.94%
Q1 2022
Q2Q % growth
8.58
202.11%
5.323.2661.43%
Q4 2021
Q2Q % growth
11.29
1,736.23%
10.101.1911.80%
Q3 2021
Q2Q % growth
7.70
1,405.08%
9.23-1.53-16.58%
Q2 2021
Q2Q % growth
6.46
2,183.87%
6.070.396.35%
Q1 2021
Q2Q % growth
2.84
911.43%
2.430.4116.66%
Q4 2020
Q2Q % growth
-0.69 -0.35-0.34-95.61%
Q3 2020
Q2Q % growth
-0.59 -0.43-0.16-35.84%
Q2 2020
Q2Q % growth
-0.31 -0.360.0513.37%
Q1 2020
Q2Q % growth
-0.35 -0.360.012.79%
MRNA Yearly EPS VS EstimatesMRNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.016B
-45.44%
904.27M111.73M12.36%
Q2 2025
Q2Q % growth
142M
-41.08%
115.2M26.8M23.26%
Q1 2025
Q2Q % growth
108M
-35.33%
108.32M-320K-0.30%
Q4 2024
Q2Q % growth
966M
-65.64%
961.7M4.3M0.45%
Q3 2024
Q2Q % growth
1.862B
1.69%
1.275B587M46.04%
Q2 2024
Q2Q % growth
241M
-29.94%
134.83M106.17M78.74%
Q1 2024
Q2Q % growth
167M
-91.03%
99.451M67.549M67.92%
Q4 2023
Q2Q % growth
2.811B
-44.71%
2.545B266M10.45%
Q3 2023
Q2Q % growth
1.831B
-45.57%
1.432B399M27.86%
Q2 2023
Q2Q % growth
344M
-92.76%
326.03M17.97M5.51%
Q1 2023
Q2Q % growth
1.862B
-69.30%
1.202B660M54.91%
Q4 2022
Q2Q % growth
5.084B
-29.50%
5.118B-34M-0.66%
Q3 2022
Q2Q % growth
3.364B
-32.30%
3.597B-233M-6.48%
Q2 2022
Q2Q % growth
4.749B
9.07%
4.147B602M14.52%
Q1 2022
Q2Q % growth
6.066B
213.16%
4.709B1.357B28.82%
Q4 2021
Q2Q % growth
7.211B
1,163.54%
6.928B283M4.08%
Q3 2021
Q2Q % growth
4.969B
3,046.93%
6.331B-1.362B-21.51%
Q2 2021
Q2Q % growth
4.354B
6,457.23%
4.292B62M1.44%
Q1 2021
Q2Q % growth
1.937B
22,959.52%
2.078B-141M-6.79%
Q4 2020
Q2Q % growth
570.7M 285M285.7M100.25%
Q3 2020
Q2Q % growth
157.9M 79.063M78.837M99.71%
Q2 2020
Q2Q % growth
66.4M 27.977M38.423M137.34%
Q1 2020
Q2Q % growth
8.4M 17.432M-9.032M-51.81%
MRNA Yearly Revenue VS EstimatesMRNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.31% 6.6% 1.09% 17.66%
Revenue0.88% -12.85% 0.1% -1.22%